These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis. Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101 [TBL] [Abstract][Full Text] [Related]
3. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bissinger EM; Heinke R; Spannhoff A; Eberlin A; Metzger E; Cura V; Hassenboehler P; Cavarelli J; Schüle R; Bedford MT; Sippl W; Jung M Bioorg Med Chem; 2011 Jun; 19(12):3717-31. PubMed ID: 21440447 [TBL] [Abstract][Full Text] [Related]
4. A patent review of arginine methyltransferase inhibitors (2010-2018). Li X; Wang C; Jiang H; Luo C Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571 [TBL] [Abstract][Full Text] [Related]
6. Small Molecule Inhibitors of Protein Arginine Methyltransferases. Hu H; Qian K; Ho MC; Zheng YG Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors of protein methyltransferases. Kaniskan HÜ; Konze KD; Jin J J Med Chem; 2015 Feb; 58(4):1596-629. PubMed ID: 25406853 [TBL] [Abstract][Full Text] [Related]
8. Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases. Li X; Zhang L; Xu J; Liu C; Zhang X; Abdelmoneim AA; Zhang Q; Ke J; Zhang Y; Wang L; Yang F; Luo C; Jin J; Ye F J Chem Inf Model; 2022 Feb; 62(3):692-702. PubMed ID: 35098713 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor. Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386 [TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation. Wang J; Chen L; Sinha SH; Liang Z; Chai H; Muniyan S; Chou YW; Yang C; Yan L; Feng Y; Li KK; Lin MF; Jiang H; Zheng YG; Luo C J Med Chem; 2012 Sep; 55(18):7978-87. PubMed ID: 22928876 [TBL] [Abstract][Full Text] [Related]
11. Small molecule regulators of protein arginine methyltransferases. Cheng D; Yadav N; King RW; Swanson MS; Weinstein EJ; Bedford MT J Biol Chem; 2004 Jun; 279(23):23892-9. PubMed ID: 15056663 [TBL] [Abstract][Full Text] [Related]
12. Histone methyltransferases in Aspergillus nidulans: evidence for a novel enzyme with a unique substrate specificity. Trojer P; Dangl M; Bauer I; Graessle S; Loidl P; Brosch G Biochemistry; 2004 Aug; 43(33):10834-43. PubMed ID: 15311944 [TBL] [Abstract][Full Text] [Related]
13. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4). Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening. Ferreira de Freitas R; Eram MS; Smil D; Szewczyk MM; Kennedy S; Brown PJ; Santhakumar V; Barsyte-Lovejoy D; Arrowsmith CH; Vedadi M; Schapira M J Med Chem; 2016 Jul; 59(14):6838-47. PubMed ID: 27390919 [TBL] [Abstract][Full Text] [Related]
15. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance. Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859 [TBL] [Abstract][Full Text] [Related]
16. A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion. Cai XC; Zhang T; Kim EJ; Jiang M; Wang K; Wang J; Chen S; Zhang N; Wu H; Li F; Dela Seña CC; Zeng H; Vivcharuk V; Niu X; Zheng W; Lee JP; Chen Y; Barsyte D; Szewczyk M; Hajian T; Ibáñez G; Dong A; Dombrovski L; Zhang Z; Deng H; Min J; Arrowsmith CH; Mazutis L; Shi L; Vedadi M; Brown PJ; Xiang J; Qin LX; Xu W; Luo M Elife; 2019 Oct; 8():. PubMed ID: 31657716 [TBL] [Abstract][Full Text] [Related]
18. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases. Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814 [TBL] [Abstract][Full Text] [Related]
19. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1). Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815 [TBL] [Abstract][Full Text] [Related]
20. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1. Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]